ClinicalTrials.Veeva

Menu

The Asian Pacific TAVR Multicenter Registry (AP TAVR)

M

Michael Kang-Yin Lee, MD

Status

Unknown

Conditions

Aortic Valve Stenosis

Treatments

Device: Transcatheter aortic valve Replacement

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02195102
AMCCV 2013-12

Details and patient eligibility

About

The purpose of this study is to evaluate the clinical outcomes of transcatheter aortic valve Replacement (TAVR) in the Asian Pacific population

Enrollment

2,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses.
  • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the appropriate Institutional Review Board/Ethics Committee of the respective clinical site.

Trial design

2,000 participants in 1 patient group

transcatheter aortic valve Replacement
Description:
Patients with symptomatic severe aortic stenosis who are not candidates for surgical aortic valve replacement because of coexisting illnesses.
Treatment:
Device: Transcatheter aortic valve Replacement

Trial contacts and locations

10

Loading...

Central trial contact

Elly Jeong-youn Bae, Research Nurse

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems